These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37993428)

  • 1. PDPN
    Li Y; Ma Z; Li W; Xu X; Shen P; Zhang SE; Cheng B; Xia J
    Cell Death Dis; 2023 Nov; 14(11):759. PubMed ID: 37993428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
    Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
    Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
    EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-β/Smad pathway.
    Yang W; Zhang S; Li T; Zhou Z; Pan J
    Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 55(2):262-273. PubMed ID: 36148955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system.
    Zhang X; Dong Y; Zhao M; Ding L; Yang X; Jing Y; Song Y; Chen S; Hu Q; Ni Y
    Theranostics; 2020; 10(26):12044-12059. PubMed ID: 33204328
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
    Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
    J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.
    Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y
    Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous carbon dioxide application suppresses the expression of cancer-associated fibroblasts markers in oral squamous cell carcinoma xenograft mouse model.
    Tadokoro Y; Takeda D; Murakami A; Yatagai N; Saito I; Arimoto S; Kakei Y; Akashi M; Hasegawa T
    PLoS One; 2023; 18(8):e0290357. PubMed ID: 37594996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
    Ochoa-Alvarez JA; Krishnan H; Pastorino JG; Nevel E; Kephart D; Lee JJ; Retzbach EP; Shen Y; Fatahzadeh M; Baredes S; Kalyoussef E; Honma M; Adelson ME; Kaneko MK; Kato Y; Young MA; Deluca-Rapone L; Shienbaum AJ; Yin K; Jensen LD; Goldberg GS
    Oncotarget; 2015 Apr; 6(11):9045-60. PubMed ID: 25826087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced lipid biosynthesis in oral squamous cell carcinoma cancer-associated fibroblasts contributes to tumor progression: Role of IL8/AKT/p-ACLY axis.
    Liu P; Wang Y; Li X; Liu Z; Sun Y; Liu H; Shao Z; Jiang E; Zhou X; Shang Z
    Cancer Sci; 2024 May; 115(5):1433-1445. PubMed ID: 38494608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer‑associated fibroblast‑derived exosomal miR‑382‑5p promotes the migration and invasion of oral squamous cell carcinoma.
    Sun LP; Xu K; Cui J; Yuan DY; Zou B; Li J; Liu JL; Li KY; Meng Z; Zhang B
    Oncol Rep; 2019 Oct; 42(4):1319-1328. PubMed ID: 31364748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.
    Suzuki J; Aokage K; Neri S; Sakai T; Hashimoto H; Su Y; Yamazaki S; Nakamura H; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Tsuboi M; Ishii G
    Lung Cancer; 2021 Mar; 153():1-10. PubMed ID: 33429158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma.
    Arebro J; Lee CM; Bennewith KL; Garnis C
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis.
    Yao F; Zhao Y; Wang G; Zhao M; Hong X; Ye Z; Dong F; Li W; Deng Q
    Cell Signal; 2024 Aug; 120():111221. PubMed ID: 38729321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin.
    Li YY; Zhou CX; Gao Y
    Exp Cell Res; 2018 Aug; 369(1):43-53. PubMed ID: 29719198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer.
    Lee HY; Yu NY; Lee SH; Tsai HJ; Wu CC; Cheng JC; Chen DP; Wang YR; Tseng CP
    Biomed J; 2020 Apr; 43(2):146-162. PubMed ID: 32441651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
    Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
    Front Immunol; 2021; 12():807600. PubMed ID: 34987523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRF3-mediated lncRNA FTX promotes cell proliferation, migration, invasion and suppresses cell apoptosis in oral squamous cell carcinoma by up-regulating FCHSD2 via miR-708-5p.
    Zhou C; Fan X; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2023 Feb; 69(2):31-36. PubMed ID: 37224049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.